LATEEF ABUMOUSSA: Open Payments
NPI 1346264900 · HENDERSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 19 payments from 13 companies in 2025. Trend: 2023 $696 · 2024 $638 · 2025 $981
Food & beverage: $981
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $158 |
| Eisai Inc. | 2 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $152 |
| Amgen Inc. | 2 | $143 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| PFIZER INC. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Lucid Diagnostics Inc. | 1 | $33 |
| Medtronic, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $27 |
Products named: UZEDY, Leqembi, Kerendia, EVENITY, BREZTRI, ELIQUIS, FANAPT, INCEPTIV.
Industry payments across NC — which companies pay providers there.
